Shutdown risks delaying FDA approval of potentially life-saving drugs and therapies

The government shutdown, now in its fifth week, threatens to delay Food and Drug Administration approval of potentially life-saving drugs and treatments.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.